George Rathmann

Recent headlines mentioning George Rathmann and Amgen (AMGN) — pulled from Finnhub + Google News. Click any headline to open the original source.

• 
  Up 231%, Is RTX Proving Why It Was a Mistake for Honeywell to Replace RTX in the Dow Jones Industrial Average?

  Yahoo· 4h ago

  Honeywell was added to the Dow for its tech focus and diversification across different end markets.

• Amgen : Statement on TAVNEOS® (avacopan)

  Finnhub· 1d ago

  Amgen Statement on TAVNEOS® On May 15, 2026, media outlets reported 20 deaths associated with patients being treated with TAVNEOS® in Japan. The report was based on a regulatory...

• Amgen : 2026 Annual Meeting of Stockholders Presentation Non GAAP Reconciliations

  Finnhub· 1d ago

  ‌Reconciliations ‌Amgen Inc. GAAP to non-GAAP Reconciliations ...

• Amgen's rare disease drug linked to deaths, liver injuries in Japan, WSJ reports

  Finnhub· 1d ago

  At least 20 people in Japan who tookAmgen's rare disease drug have died, while 22 othersdeveloped potentially fatal liver injuries, the Wall StreetJournal reported on Friday, citing partner...

• '20 People in Japan Died After Taking Amgen Drug' - Wall Street Journal

  Benzinga· 1d ago

  https://www.wsj.com/health/pharma/20-people-in-japan-died-after-taking-amgen-drug-40edaefd?mod=Searchresults&pos=1&page=1

• 
  Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

  Yahoo· 1d ago

  Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

• 
  Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration

  CNBC· 1d ago

  U.S. drugmaker Bristol Myers Squibb inked a partnership with a Chinese company that some say could mark the next wave of collaboration across continents.

• 
  Big Pharma deepens China drug partnerships amid biotech boom

  CNBC· 1d ago

  Angelica Peebles, CNBC Health and Pharmaceutical Reporter, says U.S. drugmakers are accelerating China partnerships as Bristol Myers expands biotech collaboration with Hengrui Pharma.